ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
NOVOZYMES A/S: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
-253.500M{"amount": -253500000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- NOVOZYMES A/S
- Metric
- cashflow_financing
- Period
- 2023-01-01 – 2023-12-31
- Status
- superseded
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2024-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:26:08.487466+02:00
Raw response SHA-256
301aba67a87c48da0199cce07c6e3a22…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.